|
|
||||||||
Clinical Chemistry, Vol 38, 1963-1967, Copyright © 1992 by American Association for Clinical Chemistry
D Simon, B Romestand, H Huang, G Badouaille, JA Fehrentz, B Pau, J Marchand and P Corvol
Sanofi Recherche, Montepellier, France.
A very simple, fast, and sensitive RIA of angiotensin (Ang) II has been developed, based on a monoclonal antibody with high affinity and specificity, making possible the direct measurement of circulating Ang II in human plasma after solid-phase extraction. The purified monoclonal antibody 4D8 has an association constant of 1.3 x 10(11) L/mol with Ang II and a cross-reactivity of < 1% for Ang I. The assay can detect as little as 0.8 fmol of Ang II in 2 mL of plasma and is not influenced by the presence of Ang I. Analytical recoveries between 112% and 116% were obtained for Ang II added to human plasma at physiological concentrations. Comparison of the RIA with a reversed- phase, high-performance liquid chromatographic method followed by RIA to measure Ang II in human plasma samples from normal and hypertensive subjects--and from normotensive subjects before and after an acute inhibition of angiotensin-converting enzyme with captopril (50 mg)-- showed a high degree of correlation (r2 = 0.93) between the two methods.
The following articles in journals at HighWire Press have cited this article:
![]() |
E. VilaPorcile, A. Barret, and P. Corvol Secretion of Renin-Angiotensin System (RAS) Components by Normal and Tumoral Lactotropes: A Comparative Study Using Reverse Hemolytic Plaque Assay (RHPA) and Immunoelectron Microscopy J. Histochem. Cytochem., December 1, 2000; 48(12): 1691 - 1704. [Abstract] [Full Text] |
||||
![]() |
D. Henrion, J. Benessiano, I. Philip, S. Vuillaumier-Barrot, M. Iglarz, G. Plantefeve, D. Chatel, U. Hvass, G. Durand, J.-M. Desmonts, et al. The deletion genotype of the angiotensin I-converting enzyme is associated with an increased vascular reactivity in vivo and in vitro J. Am. Coll. Cardiol., September 1, 1999; 34(3): 830 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Azizi, E. Ezan, J.-L. Reny, J. Wdzieczak-Bakala, V. Gerineau, and J. Menard Renal and Metabolic Clearance of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (AcSDKP) During Angiotensin-Converting Enzyme Inhibition in Humans Hypertension, March 1, 1999; 33(3): 879 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Laune, F. Molina, G. Ferrieres, J.-C. Mani, P. Cohen, D. Simon, T. Bernardi, M. Piechaczyk, B. Pau, and C. Granier Systematic Exploration of the Antigen Binding Activity of Synthetic Peptides Isolated from the Variable Regions of Immunoglobulins J. Biol. Chem., December 5, 1997; 272(49): 30937 - 30944. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Henrion, J. Benessiano, and B. I. Levy In Vitro Modulation of a Resistance Artery Diameter by the Tissue Renin-Angiotensin System of a Large Donor Artery Circ. Res., February 1, 1997; 80(2): 189 - 195. [Abstract] [Full Text] |
||||
![]() |
M.-L. Lachurie, M. Azizi, T.-T. Guyene, F. Alhenc-Gelas, and J. Menard Angiotensin-Converting Enzyme Gene Polymorphism Has No Influence on the Circulating Renin-Angiotensin-Aldosterone System or Blood Pressure in Normotensive Subjects Circulation, June 15, 1995; 91(12): 2933 - 2942. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |